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Abstract Background: Kawasaki disease is an acute systemic vasculitis. Cardiac complications are frequent
and include endothelial dysfunction in patients with coronary anomalies. So far, the presence of endothelial
dysfunction in patients with no coronary lesions has not been demonstrated. Peripheral arterial tonometry
(Endo-PAT) measures the microvascular function in response to local ischaemia and has been validated in
adult population, but its use in children is scarce. Aim: To evaluate endothelial dysfunction in children as a
long-term complication after Kawasaki disease using Endo-PAT. Methods: We evaluated two groups of
subjects: (1) Kawasaki disease patients over 11 years of age, diagnosed for .5 years, with no coronary lesions,
or any other risk factors for cardiovascular disease; (2) control group of individuals without cardiovascular risk
factors. Patients and controls were clinically accessed. Endo-PAT was performed to determine reactive
hyperaemia index and augmentation index. Results: A total of 35 individuals (21 males, age 216 6 years)
were evaluated (group 1: 19; controls: 16). Kawasaki disease patients presented significant lower reactive
hyperaemia index (1.686 0.49 versus 2.316 0.53; p5 0.001). Augmentation index was similar in both
groups (2106 7 versus 2116 5; p. 0.005). Most patients with Kawasaki disease disclosed endothelial
dysfunction (68%) compared with only 12% in controls. Conclusions: Endo-PAT is feasible and reproducible in
the child population. Endothelial dysfunction is a frequent long-term complication in patients after Kawasaki
disease with normal appearing coronary arteries. However, these results need validation in a larger population.
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K
AWASAKI DISEASE IS THE LEADING CAUSE OF
acquired heart disease in the developed
world.1,2 It is an acute, systemic vasculitis
of uncertain aetiology, occurring predominantly in
infants and children younger than 5 years of age.3
Coronary artery aneurysms or ectasia develop in
15–25% of Kawasaki disease patients, during its
acute stage, and may lead to myocardial infarction,
sudden death, or chronic coronary insufficiency.4 In
addition to causing acute coronary artery aneurysm
and stenosis, Kawasaki disease has also been shown
to have deleterious effects on coronary artery
function years after the acute presentation. Another
issue that raises concerns is vascular abnormalities
other than those involving coronary arteries. Several
reports indicated abnormal changes in the systemic
vascular physiology in Kawasaki disease patients with
persistent or regressed coronary artery lesions, includ-
ing increased wall thickness and decreased distensibi-
lity of the carotid arteries,5,6 and increased stiffness
of central and peripheral arteries.7 Histological
and pathological studies have identified aneurysms
at other vascular tree sites, involving mainly small- to
medium-sized vessels, including the femoral, iliac,
renal, axillary, and brachial arteries.8
Although persistent coronary artery aneurysm
only occurs in a minority of children with acute
Kawasaki disease,9 considerable attention has been
focused in the past few years on the long-term
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outcome of this subgroup, mainly because of concerns
regarding increased risk for morbidity and mortality,
late after resolution of acute Kawasaki disease.
Arterial function has been assessed in multiple
studies in which the authors evaluated myocardial
and coronary flow reserve with angiography,4,10–12
invasive flow measurements,13–15 positron emission
tomography,16,17 and transthoracic Doppler ultra-
sound of the coronary arteries.18 Abnormalities have
been observed in both endothelial-mediated and
endothelial-independent coronary artery vasodilation.
In spite of the main focus on Kawasaki disease
patients with coronary artery involvement, a small
number of studies have also shown that even in
patients with a history of Kawasaki disease without
coronary artery dilation or ischaemia coronary flow
reserve is impaired,10,16–18 although conflicting
results showed no difference from normal control
subjects.4,11,12 These results, and the decreased
number of new patients with Kawasaki disease with
coronary artery aneurysm, revived the research interest
in diagnostic assays for the assessment of endothelium
dysfunction in children with Kawasaki disease with-
out coronary artery aneurysm.15,19
In the healthy state, the endothelium produces a
number of factors, including nitric oxide, that are
essential for maintaining vascular homoeostasis.
Several risk factors damage endothelial cells, lowering
nitric oxide bioavailability. An impaired endothelial
function has been associated with an increased risk
of cardiovascular events. In spite of its relevance,
endothelial function assessment has not yet been
incorporated into routine risk stratification of patients
with Kawasaki disease, mainly because of technical
limitations.20–22 The use of novel digital tonometry
device to measure endothelial function offers the
possibility of an easily performed, rapid assessment of
microvascular function, overcoming these limitations.
The Endo-PAT device (Itamar Medical, Caesarea,
Israel) is a commercially available system, consisting
of a fingertip plethysmograph capable of sensing
volume changes in the digit with each arterial
pulsation. It has been validated in adult population
to assess microvascular function,23 but its use among
children is scarce.24,25 Therefore, our aim was to
evaluate for endothelial dysfunction in children and
young adults as a long-term complication after
Kawasaki disease using the Endo-PAT, comparing
the results with matched normal controls.
Methods
Study population
The patients, selected from our outpatient clinic,
were all aged .11 years and have had a diagnosis of
acute Kawasaki disease for .5 years previously,
diagnosed by standard criteria.2,26 Patients were
excluded if they have had coronary artery lesions
during the acute Kawasaki disease stage, or if they
had potentially confounding risk factors for endo-
thelial damage, such as smoking, elevated LDL
cholesterol, hypertension, diabetes mellitus, or a
family history of premature cardiovascular disease,
or if they were taking vasoactive medication. No
other selection criteria were applied. In all, 19
patients (12 males) aged 15–27 years (mean age,
216 6 years) were studied. Management of the
acute Kawasaki disease was determined by the
patient’s own physicians. In addition, 16 healthy
age- and sex-matched control subjects (9 males,
mean age, 216 6 years) were studied. These
subjects were normal individuals without risk
factors for endothelial damage as listed above and
were recruited from family and friends of hospital
staff. None were taking medications or had a history
of significant illness.
Study protocol
A history was obtained from all subjects, and a
physical examination was performed, including supine
blood pressure. All subjects had an electrocardiogram
and an echocardiogram performed. The medical
records of the Kawasaki disease patients were reviewed
for details of their acute illness. Endothelial function
was assessed through peripheral arterial tonometry, as
described below; the peripheral arterial tonometry
study was repeated 1 month later, in order to assess
the reproducibility of the data.
Peripheral arterial tonometry
Endothelial function tests were performed in a
dedicated laboratory, in a quiet environment, with
controlled temperature and humidity, during the
morning period, between 9:00 and 12:00 am, at least
two hours after a light breakfast without ingestion
of caffeine or other xanthines. Pulse wave amplitude
was assessed before and during reactive hyperaemia
by peripheral arterial tonometry (Endo-PAT 2000,
Itamar Medical Limited, Israel), as previously
described in detail (Fig 1).21,23 In brief, baseline
pulse wave amplitude data were collected using
plethysmographic finger cuffs, placed on the index
finger of both hands, for a period of 5 minutes. An
ischaemic stimulus was induced by cuff occlusion,
that is, inflation of a brachial cuff to a supra-systolic
pressure of 200mmHg for 5 minutes, and the pulse
wave amplitude – reactive hyperaemia index was
calculated as the ratio of the average pulse wave
amplitude value, over a 1-minute epoch starting after
cuff release, to the pre-occlusion baseline pulse wave
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amplitude value. The augmentation index, a measure
of arterial stiffness, was also computed, as the
difference from the two systolic peaks, derived from
the baseline period’s mean peripheral arterial tono-
metry waveform ensemble. A reactive hyperaemia
index cut-off value of 1.67 was used for diagnosing
endothelial dysfunction, as previously defined by
Bonetti et al.27
Statistical analysis
Continuous variables are expressed as mean6 standard
deviation, unless otherwise specified. Categorical
variables are given as frequencies and percentage
of patients. Normality of the distributions of
the continuous variables was analysed with the
Kolmogorov–Smirnov test. Student’s t-test was used
to assess all paired data in the same group.
Comparisons between groups were made using the
Mann–Whitney U-test. The chi-square test was used
for categorical variables. A value of p,0.05 was
considered statistically significant. Data were analysed
using SPSS software version 18 (IBM Corporation,
United States of America).
Results
Table 1 summarises the patient characteristics of each
group. Groups were comparable in terms of gender
distribution (women: 37% versus 43%), age (216 6
years), and body surface mass (22.8). All subjects
were well, with normal clinical and electrocardio-
gram evaluation. The Kawasaki disease patients had
normal left ventricular function and normal coronary
arteries on echocardiography. The endothelium
function studies disclosed endothelium dysfunction
in the majority (68%) of Kawasaki disease patients,
when compared with a significantly lower percentage
of control subjects (12%). There were significant
group differences in pulse wave amplitude-derived
reactive hyperaemia index, with Kawasaki disease
patients having a significantly lower reactive
hyperaemia index when compared with the control
group (1.676 0.49 versus 2.316 0.53; p5 0.001,
Fig 2). Pulse wave amplitude-derived augmentation
index was similar in both groups (2106 7 versus
2116 5; p. 0.005). The reactive hyperaemia
index values were reproducible; no statistically
significant changes were found at the 1-month
Endo-PAT retest (Table 2; p5 0.7856).
Discussion
This study has shown that endothelial dysfunction
is a long-term complication in patients after
Kawasaki disease, even in patients without detect-
able coronary involvement during the acute illness.
This is the first study, to our knowledge, to show
Figure 1.
(a and b) Pulse wave amplitude recordings with peripheral arterial
tonometry at baseline (green) during supra-systolic cuff occlusion and
during reactive hyperaemia (red) in the ischaemic arm are
demonstrated. (c) Peripheral arterial tonometry recordings from the
contralateral finger not undergoing reactive hyperaemia testing are
shown. (a) Healthy individual with no cardiovascular risk factors
showing a steady-state peripheral arterial tonometry signal (baseline),
complete disappearance of the signal during cuff inflation (occlusion),
followed by an increased peripheral arterial tonometry signal during
recovery (hyperaemia). (b) Individual with coronary artery disease
showing a blunted finger peripheral arterial tonometry response during
reactive hyperaemia. (c) Peripheral arterial tonometry recording from
the contralateral finger in the same patient (reproduced with
permission from Kuvin et al. Assessment of peripheral vascular
endothelial function with finger arterial pulse wave amplitude, Am
Heart J, 2003; 146: 168–174).
Table 1. Demographic characteristics of the subjects.
Kawasaki disease patients Control group p-value
Number of patients (n) 19 16
Male gender (n) 12 9
Age (years) 216 6 216 6 0.81
Weight (Kg) 616 15 626 14 0.94
Height (cm) 1666 9 1686 10 0.4
Values shown are mean6 SD
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microvascular endothelial dysfunction in Kawasaki
disease patients, as all the previous studies assessed
the arterial and endothelial function of large- and
medium-sized vessels. We have also demonstrated
that peripheral arterial tonometry is a feasible, safe,
and reproducible technique, in the child population,
to study endothelial function.
Kawasaki disease occurs worldwide in both
endemic and community-based epidemic forms, in
children of all races. It is a medium-vessel vascu-
litis with predominant involvement of the coronary
arteries. The search for an aetiologic agent has been
wide ranging. Some investigators believe that an
infectious agent triggers a typical immune response,
in phenotypically susceptible individuals, resulting
in the clinical manifestations of the disease. Regard-
less of the initiating event, Kawasaki disease is
accompanied by significant derangements in the
immunoregulatory system28–30 that lead to coronary
inflammation and coronary artery abnormalities,
dilatation, aneurysm formation, and giant aneurysms
in some patients. Endothelial cell damage appears to
occur as a result of this increased immune activity.31
In addition to causing coronary artery aneurysm and
stenoses, Kawasaki disease has also been shown to
have deleterious effects on coronary artery function
years after the acute presentation. In patients with
persistent coronary artery aneurysm, coronary artery
function has repeatedly been shown to be impaired
compared with control subjects.4,11,12,32,33 Coronary
flow reserve is also abnormal in patients with a
history of transiently dilated coronary arteries.4,34
Even in patients with a history of Kawasaki disease
without antecedent coronary artery dilation or
ischaemia, impaired coronary flow reserve has been
observed.10,13,16,34 The inflammatory insult asso-
ciated with acute Kawasaki disease has the potential
to affect not only the coronary arteries, but also all
components of the cardiovascular system. Our
finding of late functional abnormalities, of the
endothelial-dependent microvascular relaxation, in
the majority of the Kawasaki disease group in our
study may be a consequence of this systemic
inflammation. These findings raise concerns that
the risk of late cardiovascular complications may not
be confined to those patients with detectable early
coronary artery aneurysm.
Although the first study of this kind was
conducted more than a decade ago, only recently
the interest in this area was revived, and a number
of similar studies have appeared in the literature.
Most of these studies were conducted in children
with Kawasaki disease having coronary artery
aneurysm. Our results are inline with the one from
Dhillon et al,35 which demonstrated abnormal flow-
mediated dilation of the brachial artery in 20 male
subjects, who were studied 5–17 years after the
onset of Kawasaki disease, irrespective of whether
they had developed aneurysms during the acute
phase. Deng et al36 and Dalla Pozza et al37 have
reported endothelial dysfunction in a small number
of children with Kawasaki disease, but without
coronary artery aneurysms. Our study adds evidence
to these findings and suggests that the occurrence of
Kawasaki disease may have lifelong consequences
Figure 2.
Pulse wave amplitude-derived reactive hyperaemia index in
Kawasaki disease and control groups. The reactive hyperaemia
index values were significantly lower in the Kawasaki disease
patients than those in the male control subjects.
Table 2. RHI values for the Kawasaki disease group.
Patient number Gender RHI 1 RHI 2
Patient 1 Female 1.6 1.55
Patient 2 Female 1.56 2.02
Patient 3 Female 1.48 1.3
Patient 4 Male 3.17 2.81
Patient 5 Male 1.35 1.42
Patient 6 Male 1.14 1.05
Patient 7 Male 1.8 2
Patient 8 Male 1.24 1.51
Patient 9 Male 1.64 1.34
Patient 10 Male 1.4 1.52
Patient 11 Male 1.69 1.62
Patient 12 Male 1.46 1.5
Patient 13 Female 1.63 1.75
Patient 14 Male 2.63 2.6
Patient 15 Male 1.35 1.2
Patient 16 Female 1.58 1.67
Patient 17 Female 1.28 1.51
Patient 18 Female 2.18 2.1
Patient 19 Male 1.5 1.45
Average 1.676 0.49 1.686 0.45
RHI5 reactive hyperaemia index
Values shown are mean6 SD. RHI 1 – basal reactive hyperaemia
index value; RHI 2 –reactive hyperaemia index value, 1 month after
the first test.
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even when there is no discernible coronary artery
involvement. The issue, however, is rather conten-
tious. In studies of Japanese subjects, of comparable
characteristics, only the ones who developed coronary
artery aneurysms during the acute stage of Kawasaki
disease had abnormal flow-mediated dilation.38,39
The authors of a recent study40 of 52 Canadian
Kawasaki disease patients concluded that there was
no evidence of long-term endothelial cell dysfunction
late after Kawasaki disease. It is unclear whether
these conflicting results are best explained by
methodological issues or genetic differences of the
populations studied.
Children with Kawasaki disease, with or without
coronary artery lesions, may have a more adverse
cardiovascular risk profile. Whether this is a cause or
a consequence of an abnormal endothelial function has
not yet been assessed.40,41 What is noteworthy is the
fact that, in our sample, almost 70% of our Kawasaki
disease group had an abnormal endothelial function,
when compared with only 12% of the control group
subjects.
Our findings may have surveillance and thera-
peutic implications for the Kawasaki disease patients
who had no coronary artery involvement during the
acute disease. In the current management practices,
long-term follow-up of these patients is seldom
undertaken. Our results suggest that children with
Kawasaki disease may have long-term sequelae, even
when there is no overt coronary artery involvement
in the acute stage of the disease. Affected children
should therefore be kept on long-term follow-up, and
instructed to avoid known cardiovascular risk factors,
such as sedentary lifestyle, overweight, high-lipid and
-caloric meals, alcohol or tobacco use. Prospective
work is required, in a larger population, to assess the
potential benefit of therapeutic approaches to these
patients. The availability of newer, simple, and
reproducible non-invasive techniques will allow a
more rigorous follow-up of the endothelial function
in these patients, allowing a close monitoring of the
therapeutical effectiveness.
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